Method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablet
Through 0.1% water-acetonitrile dissolution ultrasonic method and LC-MS/MS detection method, the interference problem of NTTP detection in sitagliptin phosphate tablets was solved, and fast and accurate NTTP detection was achieved to ensure sitagliptin phosphate tablets were quality control improves drug safety.
Patent Information
- Application Number
- CN202410967729.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-18
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art lacks efficient and accurate methods to detect NTTP of nitrosamine impurity in sitagliptin phosphate tablets, especially when the auxiliary material has high content, which leads to interference in the detection results and is difficult to achieve fast and accurate quality control.
The fine powder of sitagliptin phosphate tablets was converted into the test solution by 0.1% water phosphate-acetonitrile dissolving ultrasonic method, and the LC-MS/MS method was used to detect it. The content of NTTP was determined by gradient elution and mass spectrometry. , break the interference of auxiliary materials, improve recovery rate and detection accuracy.
It realizes fast, accurate, stable and repeatable NTTP detection, can determine the presence and content of impurities within 1 minute, and the recovery rate is close to 100%. It is suitable for the quality control of sitagliptin phosphate tablets to ensure drug safety.
Smart Images

Figure CN118914389A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to the technical field of drug analysis, and in particular to a method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablets. Background Art
[0002] The information disclosed in the background of the invention is only intended to enhance the understanding of the overall background of the invention and should not be necessarily regarded as an acknowledgment or any form of suggestion that the information constitutes the prior art already known to a person skilled in the art.
[0003] Sitagliptin phosphate tablets (trade name JANUVIA) were approved for marketing by the U.S. FDA in October 2006. They can be used alone or in combination with other oral hypoglycemic drugs (such as metformin or thiazolidinediones) to treat type 2 diabetes.
[0004] The production process of sitagliptin phosphate API uses a key raw material: 3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-α]pyrazine (starting material 3). NTTP is produced by the reaction of this raw material with nitrite compounds in the subsequent process, as shown in the following formula:
[0005]
[0006] Since the raw material (starting material 3) is unavoidable in the production process of sitagliptin phosphate, and it will also degrade to produce the impurity starting material 3 during storage, there is a risk of producing NTTP impurities in sitagliptin phosphate. According to the limits and classifications of nitrosamine impurities published by EMA, the limit is 37ng / day, which is very similar to the Class 1 limit in the CPCA classification (18ng / day). It is highly toxic and is classified as Class 1 based on the AI value of NDEA, which has the strongest carcinogenicity.
[0007] At present, the detection method of NTTP impurities is not included in the pharmacopoeias of various countries. Other Indian patents only have the detection method of sitagliptin phosphate raw materials, and there is no NTTP control in the preparation. The weight of sitagliptin phosphate tablets is 400 mg, and various excipients account for more than 68wt%. When measuring NTTP, due to the packaging of excipients in the tablets, it causes great interference to the measurement results. Therefore, how to provide an efficient, convenient, fast, highly specific and accurate method for detecting nitrosamine impurities NTTP in sitagliptin phosphate tablets to control the quality of sitagliptin phosphate tablets is an urgent problem to be solved. Summary of the invention
[0008] In view of this, the present invention provides a method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablets, which makes up for the lack of detection methods for NTTP in preparations, and the detection method is convenient, efficient, highly specific and highly accurate.
[0009] The present invention provides a method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablets, comprising the following steps:
[0010] The fine powder of Sitagliptin phosphate tablets was dissolved in 0.1% phosphoric acid water-acetonitrile, sonicated, and filtered to obtain a test solution;
[0011] The test solution was determined by LC-MS / MS method to obtain the content of nitrosamine impurity NTTP in sitagliptin phosphate tablets;
[0012] Wherein, the structural formula of the nitrosamine impurity NTTP is shown in formula (I):
[0013]
[0014] Preferably, in the 0.1% phosphoric acid water-acetonitrile, the volume ratio of 0.1% phosphoric acid water to acetonitrile is (90-98):(2-10).
[0015] Preferably, the dosage ratio of sitagliptin to 0.1% phosphoric acid water-acetonitrile in the sitagliptin phosphate tablet fine powder is 100 mg: (8-12) mL.
[0016] Preferably, the ultrasonic time is 20 to 40 minutes.
[0017] Preferably, in the LC-MS / MS method, the chromatographic conditions are as follows:
[0018] The chromatographic column is filled with octadecylsilane bonded silica gel;
[0019] The mobile phase consists of a mobile phase A and a mobile phase B, wherein the mobile phase A is an aqueous solution containing 0.1 to 0.2% formic acid, and the mobile phase B is a methanol solution containing 0.1 to 0.2% formic acid;
[0020] The elution method is gradient elution, and the conditions of the gradient elution are:
[0021] Time (min) Mobile phase A (%) Mobile phase B (%) 0.0 70~80 30~20 2.0 70~80 30~20 2.1 5~15 95~85 4.0 5~15 95~85 4.1 70~80 30~20 10.0 70~80 30~20
[0022] The flow rate was 0.2-0.4 mL / min and the column temperature was 38-42 °C.
[0023] Furthermore, the mobile phase A is an aqueous solution containing 0.12% formic acid, and the mobile phase B is a methanol solution containing 0.12% formic acid.
[0024] Further, the conditions of the gradient elution are:
[0025]
[0026]
[0027] The flow rate was 0.3 mL / min and the column temperature was 40 °C.
[0028] Preferably, the mass spectrometry conditions of the LC-MS / MS method are:
[0029] The ion source is an electron bombardment source, the ion source temperature is 340-360°C, the vaporization chamber temperature is 340-360°C, the scanning mode is SRM, wherein Q1 is 222.08, Q3 is 192.04, the collision energy is 10.64V; and the injection volume is 4-6μL.
[0030] Preferably, the method for determining the content of the nitrosamine impurity NTTP in the sitagliptin phosphate tablets is specifically as follows: taking a reference solution of the nitrosamine impurity NTTP, determining it using the LC-MS / MS method to obtain a mass spectrum, and calculating the content of the nitrosamine impurity NTTP in the test solution by the peak area using the external standard method.
[0031] Furthermore, the preparation method of the reference solution of the nitrosamine impurity NTTP is as follows: take an appropriate amount of the nitrosamine impurity NTTP, accurately weigh it, add 0.1% phosphoric acid water-acetonitrile to dissolve it and dilute it to prepare a solution with a nitrosamine impurity NTTP content of 3-5 ng / mL.
[0032] In a second aspect, the present invention provides an application of the above detection method in the quality control of sitagliptin phosphate tablets to control the content of nitrosamine impurity NTTP within 0.37 ppm.
[0033] Compared with the prior art, the present invention has achieved the following beneficial effects:
[0034] The detection method of the present invention can quickly and effectively detect the content of nitrosamine impurity NTTP in sitagliptin phosphate tablets, and the presence and content of nitrosamine impurity NTTP can be determined within 1 minute. The detection method of the present invention is accurate and reliable, easy to operate, fast, highly stable, repeatable and durable, and can effectively break the interference of auxiliary materials on NTTP, and the recovery rate is close to 100%. The detection method of the present invention makes up for the vacancy of NTTP detection methods in preparations, and can be used in the quality control of sitagliptin phosphate tablet drug production. BRIEF DESCRIPTION OF THE DRAWINGS
[0035] The drawings constituting part of the present invention are used to provide a further understanding of the present invention. The exemplary embodiments of the present invention and their description are used to explain the present invention and do not constitute an improper limitation of the present invention. Obviously, for those skilled in the art, other drawings can be obtained based on these drawings without creative work.
[0036] Figure 1 It is a concentration-peak area linear curve of the nitrosamine impurity NTTP in Example 1 of the present invention. DETAILED DESCRIPTION
[0037] It should be noted that the following detailed descriptions are exemplary and are intended to provide further explanation of the present invention. Unless otherwise specified, all technical and scientific terms used herein have the same meanings as those commonly understood by those skilled in the art to which the present invention belongs.
[0038] The present invention provides a method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablets, comprising the following steps:
[0039] The fine powder of Sitagliptin phosphate tablets was dissolved in 0.1% phosphoric acid water-acetonitrile, sonicated, and filtered to obtain a test solution;
[0040] The test solution was determined by LC-MS / MS method to obtain the content of nitrosamine impurity NTTP in sitagliptin phosphate tablets;
[0041] Wherein, the structural formula of the nitrosamine impurity NTTP is shown in formula (I):
[0042]
[0043] The present invention finds that the content of auxiliary materials in sitagliptin phosphate tablets accounts for more than 68wt%, and the auxiliary materials will cause great interference to the detection of NTTP. When water is used as a solvent, the recovery rate is very low, which will cause the illusion of non-detection. The present invention adds phosphoric acid and acetonitrile to the solvent to break the package of the auxiliary materials, thereby improving the recovery rate of NTTP and improving the accuracy of detection. The present invention adopts LC-MS / MS method (liquid chromatography-mass spectrometry) for detection, and the detection efficiency is high.
[0044] The present invention does not impose any particular limitation on the preparation method of the sitagliptin phosphate tablet fine powder, and the preparation method of tablet fine powder commonly used in the art can be adopted.
[0045] In the present invention, the volume ratio of 0.1% phosphoric acid water to acetonitrile is (90-98):(2-10), more preferably (93-97):(3-7), and most preferably 95:5. In the present invention, the percentage in 0.1% phosphoric acid water refers to the volume ratio.
[0046] In the present invention, the dosage ratio of sitagliptin in the sitagliptin phosphate tablet fine powder to 0.1% phosphoric acid water-acetonitrile is 100 mg: (8-12) mL.
[0047] In the present invention, the ultrasonic time is 20 to 40 minutes, more preferably 25 to 35 minutes, and most preferably 30 minutes.
[0048] The preparation method of the test solution of the present invention is specifically as follows: dissolving the sitagliptin phosphate tablets with 0.1% phosphoric acid water-acetonitrile accounting for 50-80% of the total volume, ultrasonicating for 20-40 minutes, diluting to the scale with 0.1% phosphoric acid water-acetonitrile, shaking well, filtering, and obtaining the solution.
[0049] In the present invention, in the LC-MS / MS method, the chromatographic conditions are as follows:
[0050] The chromatographic column uses octadecylsilane bonded silica gel as a filler; the model of the chromatographic column is DLC-XB-C18, 2.1mm×50mm, 1.8μm or a chromatographic column with equivalent performance.
[0051] The mobile phase of the present invention is composed of mobile phase A and mobile phase B, wherein the mobile phase A is an aqueous solution containing 0.1-0.2% formic acid, and the mobile phase B is a methanol solution containing 0.1-0.2% formic acid; more preferably, the mobile phase A is an aqueous solution containing 0.12% formic acid, and the mobile phase B is a methanol solution containing 0.12% formic acid. In the present invention, the percentages in the aqueous solution containing 0.1-0.2% formic acid and the methanol solution containing 0.1-0.2% formic acid refer to volume fractions.
[0052] The elution method of the present invention is gradient elution, and the conditions of the gradient elution are:
[0053] Time (min) Mobile phase A (%) Mobile phase B (%) 0.0 70~80 30~20 2.0 70~80 30~20 2.1 5~15 95~85 4.0 5~15 95~85 4.1 70~80 30~20 10.0 70~80 30~20
[0054] More preferably, the conditions of the gradient elution are:
[0055] Time (min) Mobile phase A (%) Mobile phase B (%) 0.0 75 25 2.0 75 25 2.1 10 90 4.0 10 90 4.1 75 25 10.0 75 25
[0056] In the present invention, the peak time of the nitrosamine impurity NTTP is between 0.7 and 0.75 min, and the presence of the nitrosamine impurity NTTP can be determined within 1 min, and the detection time is very short.
[0057] The flow rate of the mobile phase of the present invention is 0.2-0.4 mL / min, more preferably 0.3 mL / min; the column temperature is 38-42° C., more preferably 40° C.
[0058] In the present invention, the mass spectrometry conditions of the LC-MS / MS method are:
[0059] The ion source is an electron bombardment source, the ion source temperature is 340-360°C, more preferably 345-355°C, and most preferably 350°C; the vaporization chamber temperature is 340-360°C, more preferably 345-355°C, and most preferably 350°C; the scanning mode is SRM, wherein Q1 is 222.08, Q3 is 192.04, and the collision energy is 10.64V; the injection volume is 4-6μL, and most preferably 5μL.
[0060] In the present invention, the method for determining the content of the nitrosamine impurity NTTP in the sitagliptin phosphate tablets is specifically as follows: taking a reference solution of the nitrosamine impurity NTTP, determining it by the LC-MS / MS method, obtaining a mass spectrum, and calculating the content of the nitrosamine impurity NTTP in the test solution by the peak area using the external standard method.
[0061] In the present invention, the preparation method of the reference solution of the nitrosamine impurity NTTP is as follows: take an appropriate amount of the nitrosamine impurity NTTP, accurately weigh it, add 0.1% phosphoric acid water-acetonitrile to dissolve it and dilute it to prepare a solution with a nitrosamine impurity NTTP content of 3 to 5 ng / mL. In the reference solution of the nitrosamine impurity NTTP, the content of the nitrosamine impurity NTTP is most preferably 4 ng / mL.
[0062] The present invention also provides an application of the above detection method in the quality control of sitagliptin phosphate tablets, controlling the content of nitrosamine impurity NTTP within 0.37ppm to avoid the adverse effects of nitrosamine impurity NTTP on the human body. According to the limits and classifications of nitrosamine impurities published by EMA, the limit is 37ng / day, and the maximum dosage of sitagliptin phosphate tablets (100mg / day), so the limit of NTTP is set at 0.37ppm.
[0063] The technical solution of the present invention is further described below in conjunction with specific embodiments. In the following embodiments, the percentage in 0.1% phosphoric acid aqueous solution refers to the volume fraction, and the percentage in 0.12% formic acid water refers to the volume fraction.
[0064] Example 1 Linearity Experiment
[0065] Take an appropriate amount of nitrosamine impurity NTTP reference substance, accurately weigh it, add a solvent 0.1% phosphoric acid water-acetonitrile (95:5, v / v), ultrasonically dissolve it and dilute it to make a solution containing about 100 ng per 1 mL as the linear stock solution; accurately measure 1 mL, 2 mL, 3 mL, 4 mL, 6 mL, and 10 mL respectively, place them in different 100 mL volumetric flasks, dilute to the scale with solvent, shake well, and use them as the linear test series concentration solutions.
[0066] Accurately measure 5 μL of each of the above linear test series solutions, inject them into a mass spectrometer (LC-MS / MS), and record the mass spectrum.
[0067] The peak area was linearly regressed with concentration, and the relevant parameters and results are shown in Table 1. Figure 1 The concentration-peak area linear curve of the nitrosamine impurity NTTP is shown in FIG. The linear relationship is good within the concentration range of 0.385 to 9.625 ng / mL (i.e., 0.0385 ppm to 0.9625 ppm), the correlation coefficient is 0.9991, and the ratio of the intercept to the 100% response value is 2.54%.
[0068] Table 1 Linearity test and results
[0069]
[0070] Example 2
[0071] Solvent: 0.1% phosphoric acid water-acetonitrile (95:5, v / v).
[0072] Test solution: Take an appropriate amount of fine powder of this product (equivalent to approximately 100 mg of sitagliptin), place it in a 10 mL volumetric flask, add an appropriate amount of solvent, ultrasonicate for 30 minutes, cool, dilute to the scale with solvent, shake well, and filter.
[0073] Reference solution: Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, add solvent to dissolve and dilute it to make a solution containing 4 ng of nitrosamine impurity NTTP per 1 mL.
[0074] Chromatographic conditions: octadecylsilane bonded silica gel is used as filler (DLC-XB-C18, 2.1 mm×50 mm, 1.8 μm or a chromatographic column with equivalent performance); water containing 0.12% formic acid is used as mobile phase A; methanol solution containing 0.12% formic acid is used as mobile phase B; linear gradient elution is performed according to the gradient elution program in Table 2.
[0075] Table 2 Gradient elution program
[0076] Time (min) Mobile phase A (%) Mobile phase B (%) 0.0 75 25 2.0 75 25 2.1 10 90 4.0 10 90 4.1 75 25 10.0 75 25
[0077] The flow rate was 0.3 mL / min; the column temperature was 40°C; a mass spectrometer detector was used, the ion source was an electron bombardment source (H-ESI), the ion source temperature was 350°C, the vaporization chamber temperature was 350°C, the scanning mode was SRM (Q1: 222.08, Q3: 192.04 (quantitative ion), collision energy: 10.64 V); the injection volume was 5 μL.
[0078] Determination method: Accurately measure the test solution and the reference solution, inject them into the mass spectrometer (LC-MS / MS) respectively, and record the mass spectrum. Determine by liquid chromatography-mass spectrometry (LC-MS / MS, General Rules 0512 and General Rules 0431 of Part IV of the 2020 Edition of the Chinese Pharmacopoeia).
[0079] 1. Limit of Quantitation Test
[0080] Take an appropriate amount of nitrosamine impurity NTTP, add solvent to dissolve and dilute to make a series of concentration solutions, with S / N (signal to noise ratio) ≈ 10 as the quantitative limit and S / N (signal to noise ratio) ≈ 3 as the detection limit. Table 3 shows the test results of sitagliptin phosphate tablets-nitrosamine impurity NTTP inspection-quantitative limit and detection limit.
[0081] Table 3 Sitagliptin Phosphate Tablets - Nitrosamine Impurity NTTP Test - Quantitative Limit and Detection Limit Test Results
[0082]
[0083] The quantitative limit concentration solution was sampled 6 times continuously and the mass spectrum was recorded. Table 4 shows the results of the repeatability test of the NTTP test of sitagliptin phosphate tablets-nitrosamine impurities (t R represents retention time).
[0084] Table 4 Sitagliptin Phosphate Tablets - Nitrosamine Impurity NTTP Test - Quantitative Limit Repeatability Test Results
[0085]
[0086] The test results showed that the RSD% of retention time was 0.48%, the RSD% of peak area was 6.79%, and the quantitative limit had good repeatability.
[0087] 2. Repeatability test of reference substance
[0088] Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, add solvent to dissolve and dilute it to make a solution containing about 4 ng of nitrosamine impurity NTTP per 1 mL, which is used as the reference solution.
[0089] Accurately measure 5 μL, inject into mass spectrometer (LC-MS / MS), and record mass spectrum. Repeat injection 6 times. Table 5 shows the results of NTTP test for Sitagliptin Phosphate Tablets-nitrosamine impurity-repeatability test.
[0090] Table 5 Sitagliptin Phosphate Tablets - Nitrosamine Impurity NTTP Test - Repeatability Test Results
[0091] Impurity A 1 2 3 4 5 6 average RSD% 95% LCI 95% HCI tR(min) 0.743 0.731 0.729 0.726 0.726 0.727 0.730 0.90 0.723 0.736 Peak area 474.268 502.812 499.232 493.957 499.460 492.310 493.673 2.08 482.905 504.441
[0092] Note: 95% LCI (Lower limit of confident interval) is the lower limit of 95% confidence interval, and 95% HCI (High limit of confident interval) is the upper limit of 95% confidence interval.
[0093] The test results showed that the RSD% of the peak area of the reference solution was 2.08%, with good repeatability.
[0094] 3. Precision test
[0095] Take an appropriate amount of fine powder of this product (equivalent to approximately 100 mg of sitagliptin), place it in a 10 mL volumetric flask, add an appropriate amount of solvent, ultrasonicate for 30 minutes, cool, dilute to the scale with solvent, shake well, filter, and use as the test solution.
[0096] Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, dissolve it in solvent and dilute it to make a solution containing about 4ng of nitrosamine impurity NTTP per 1mL as the reference solution. Determine it in the same way and calculate it by peak area according to the external standard method.
[0097] 5 μL was accurately measured and injected into the mass spectrometer (LC-MS / MS) to record the mass spectrum. The precision test results are shown in Table 6.
[0098] Table 6 Sitagliptin Phosphate Tablets - NTTP Determination of Nitrosamine Impurities - Precision Test Results
[0099]
[0100] The test results show that after repeated determination for 6 times, the range of the determination results is less than 0.05ppm. This method has good repeatability in determining the nitrosamine impurity NTTP in sitagliptin phosphate tablets.
[0101] 4. Stability test
[0102] Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, add solvent to dissolve and dilute it to make a solution containing about 4 ng of nitrosamine impurity NTTP per 1 mL, which is used as the reference solution.
[0103] Take an appropriate amount of fine powder of this product (batch 2022030701) (approximately equivalent to 100 mg of sitagliptin), place it in a 10 mL volumetric flask, add an appropriate amount of solvent, ultrasonicate for 30 minutes, cool, dilute to the scale with solvent, shake well, filter, and use as the test solution.
[0104] The reference solution and the test solution were placed at room temperature for 24 hours, at 0 hour, 2 hours, 4 hours, 6 hours and 8 hours respectively.
[0105] Accurately measure 5 μL of the above solution, inject it into the mass spectrometer (LC-MS / MS), and record the mass spectrum. The stability test results of the reference solution and the test solution are shown in Table 7 and Table 8, respectively.
[0106] Table 7 Sitagliptin Phosphate Tablets - Nitrosamine Impurity NTTP Test - Reference Solution Stability Test Results
[0107] time 0h 2h 4h 6h 8h average RSD% Peak area 449.2252 440.1621 432.8597 435.8529 431.6240 437.9448 1.63
[0108] Table 8 Sitagliptin Phosphate Tablets - Nitrosamine Impurity NTTP Test - Test Solution Stability Test Results
[0109] time 0h 2h 4h 6h 8h average RSD% Very bad Test sample (ppm) 0.28 0.28 0.28 0.29 0.28 0.28 1.59 0.01
[0110] The test results show that after the test solution is placed at room temperature for 8 hours, the nitrosamine impurity NTTP meets the requirements and the range is less than 0.05ppm; the reference solution is placed at room temperature for 8 hours and the RSD of the peak area is less than 3.0%, indicating that the test solution and the reference solution are stable when placed at room temperature for 8 hours.
[0111] 5. Durability test
[0112] In order to ensure the durability of the existing conditions for the detection of the impurity NTTP, the column temperature, flow rate, formic acid addition amount, mobile phase ratio and different batches of chromatographic columns were designed to test the durability of the NTTP detection amount in the chromatographic conditions. The conditions are shown in Table 9.
[0113] Table 9 Durability test conditions
[0114]
[0115]
[0116] Test solution: Take an appropriate amount of fine powder of this product (equivalent to approximately 100 mg of sitagliptin), place it in a 10 mL volumetric flask, add an appropriate amount of solvent, ultrasonicate for 30 minutes, cool, dilute to the scale with solvent, shake well, and filter.
[0117] Reference solution: Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, add solvent to dissolve and dilute it to make a solution containing about 4 ng of nitrosamine impurity NTTP per 1 mL.
[0118] 5 μL of the above solution was accurately measured, the above parameters were changed, and the solution was injected into a mass spectrometer (LC-MS / MS) to record the mass spectrum. The durability test results are shown in Table 10.
[0119] Table 10 Sitagliptin Phosphate Tablets - Nitrosamine Impurities NTTP Inspection - Durability Test Results
[0120]
[0121]
[0122] The test results show that slight changes in the above chromatographic conditions have no significant effect on the NTTP determination results. The range of the determination results is 0.02%, the average value is 0.27ppm, and the RSD% is 2.33%, indicating that the chromatographic conditions have good durability.
[0123] 6. Accuracy test
[0124] Take an appropriate amount of nitrosamine impurity NTTP, accurately weigh it, add solvent to dissolve and dilute it to make a solution containing about 20ng of nitrosamine impurity NTTP per 1mL, which is used as the accuracy series stock solution. In the following experiments, the blank excipient is a mixture of microcrystalline cellulose, anhydrous calcium hydrogen phosphate, cross-linked carboxymethyl cellulose sodium, magnesium stearate, sodium stearyl fumarate and film coating premix (mass ratio is 30.94:30.94:2:1:2:1). When testing the recovery rate in the raw material, the components in the recovery rate solution are the raw material of this product + nitrosamine impurity NTTP; when testing the recovery rate in the preparation, the components in the recovery rate solution are the raw material of this product + blank excipient (excipient) + nitrosamine impurity NTTP.
[0125] Take appropriate amount of raw material of this product (equivalent to 100 mg of sitagliptin) and about 270 mg of blank auxiliary material, weigh accurately, place in a 10 mL volumetric bottle, accurately measure 0.5 mL of accuracy stock solution, ultrasonicate for 30 minutes, cool, dilute to scale with solvent, shake well, filter, and use as 25% recovery rate solution. Prepare three copies in the same way.
[0126] Take appropriate amount of raw material of this product (equivalent to 100 mg of sitagliptin) and about 270 mg of blank auxiliary material, weigh accurately, place in a 10 mL volumetric flask, accurately measure 1 mL of the accuracy stock solution, ultrasonicate for 30 minutes, cool, dilute to scale with solvent, shake well, filter, and use as 50% recovery rate solution. Prepare three copies in the same way.
[0127] Take appropriate amount of raw material of this product (equivalent to 100 mg of sitagliptin) and about 270 mg of blank auxiliary material, weigh accurately, place in a 10 mL volumetric bottle, accurately measure 2 mL of accuracy stock solution, ultrasonicate for 30 minutes, cool, dilute to scale with solvent, shake well, filter, and use as 100% recovery rate solution. Prepare three copies in the same way.
[0128] Take appropriate amount of raw material of this product (equivalent to 100 mg of sitagliptin) and about 270 mg of blank auxiliary material, weigh accurately, place in a 10 mL volumetric bottle, accurately measure 3 mL of accuracy stock solution, ultrasonicate for 30 minutes, cool, dilute to scale with solvent, shake well, filter, and use as 150% recovery rate solution. Prepare three copies in the same way.
[0129] Take appropriate amount of raw material of this product (equivalent to 100 mg of sitagliptin) and about 270 mg of blank auxiliary material, weigh accurately, place in a 10 mL volumetric bottle, accurately measure 5 mL of accuracy stock solution, ultrasonicate for 30 minutes, cool, dilute to scale with solvent, shake well, filter, and use as 250% recovery rate solution. Prepare three copies in the same way.
[0130] Take an appropriate amount of nitrosamine impurity NTTP, weigh it accurately, add solvent to dissolve and dilute it to make a solution containing about 4 ng of nitrosamine impurity NTTP per 1 mL, which is used as the reference solution.
[0131] The above operation was repeated using water, water-acetonitrile (95:5, v / v), 0.1% phosphoric acid water, and 0.1% phosphoric acid water-acetonitrile (95:5, v / v) as solvents.
[0132] Accurately measure 5 μL of the test solution and reference solution, inject into the mass spectrometer (LC-MS / MS), and record the mass spectrum. The recovery rate in the raw material (no excipients are added to the raw material) and the recovery rate in the preparation (excipients are added to the raw material) test results are shown in Table 11 and Table 12, respectively.
[0133] Table 11 Recovery rate in raw materials (no auxiliary materials added to the raw materials) Determination results
[0134]
[0135]
[0136] Table 12 Recovery in preparation (addition of auxiliary materials to raw materials) determination results:
[0137]
[0138]
[0139] The test results show that the recovery rate of the raw material in different solvents is basically unchanged and meets the requirements when the content of genotoxic impurities (NTTP) is determined by mass spectrometry (LC-MS / MS). However, due to the encapsulation of the auxiliary materials in the preparation, the recovery rates in different solvents vary greatly. The present invention significantly improves and increases the recovery rate by adding an acidic solvent and an organic phase to the solvent to break the encapsulation of the auxiliary materials. The recovery rate is best in a solvent of 0.1% phosphoric acid water-acetonitrile (95:5, v / v).
[0140] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. A method for detecting nitrosamine impurity NTTP in sitagliptin phosphate tablets, It is characterized in that The steps include: The fine powder of Sitagliptin phosphate tablets was dissolved in 0.1% phosphoric acid water-acetonitrile, sonicated, and filtered to obtain a test solution; The test solution was determined by LC-MS / MS method to obtain the content of nitrosamine impurity NTTP in sitagliptin phosphate tablets; Wherein, the structural formula of the nitrosamine impurity NTTP is shown in formula (I):
2. The detection method according to claim 1, It is characterized in that In the 0.1% phosphoric acid water-acetonitrile, the volume ratio of 0.1% phosphoric acid water to acetonitrile is (90-98):(2-10).
3. The detection method according to claim 1, It is characterized in that The dosage ratio of sitagliptin in the sitagliptin phosphate tablet fine powder to 0.1% phosphoric acid water-acetonitrile is 100 mg: (8-12) mL; and the ultrasonic time is 20-40 min.
4. The detection method according to claim 1, It is characterized in that In the LC-MS / MS method, the chromatographic conditions are as follows: The chromatographic column is filled with octadecylsilane bonded silica gel; The mobile phase consists of a mobile phase A and a mobile phase B, wherein the mobile phase A is an aqueous solution containing 0.1-0.2% formic acid, and the mobile phase B is a methanol solution containing 0.1-0.2% formic acid.
5. The detection method according to claim 4, It is characterized in that The elution mode of the mobile phase is gradient elution, and the conditions of the gradient elution are: The flow rate was 0.2-0.4 mL / min and the column temperature was 38-42 °C.
6. The detection method according to claim 4, It is characterized in that The mobile phase A is an aqueous solution containing 0.12% formic acid, and the mobile phase B is a methanol solution containing 0.12% formic acid; the gradient elution conditions are: The flow rate was 0.3 mL / min and the column temperature was 40 °C.
7. The detection method according to claim 1, It is characterized in that The mass spectrometry conditions of the LC-MS / MS method are: The ion source is an electron bombardment source, the ion source temperature is 340-360°C, the vaporization chamber temperature is 340-360°C, the scanning mode is SRM, wherein Q1 is 222.08, Q3 is 192.04, the collision energy is 10.64V; and the injection volume is 4-6μL.
8. The detection method according to claim 1, It is characterized in that The method for determining the content of the nitrosamine impurity NTTP in the sitagliptin phosphate tablets is specifically as follows: taking a reference solution of the nitrosamine impurity NTTP, determining it using the LC-MS / MS method to obtain a mass spectrum, and calculating the content of the nitrosamine impurity NTTP in the test solution using the peak area using the external standard method.
9. The detection method according to claim 8, It is characterized in that The preparation method of the reference solution of the nitrosamine impurity NTTP is as follows: take an appropriate amount of the nitrosamine impurity NTTP, accurately weigh it, add 0.1% phosphoric acid water-acetonitrile to dissolve it and dilute it to prepare a solution with a nitrosamine impurity NTTP content of 3-5 ng / mL.
10. Use of the detection method according to any one of claims 1 to 9 in quality control of sitagliptin phosphate tablets, It is characterized in that The content of nitrosamine impurity NTTP is controlled within 0.37ppm.
Citation Information
Patent Citations
Method for detecting fumaric acid impurities related to chlorpheniramine maleate and preparation thereof
CN117074585A
Method for simultaneously detecting contents of NTTP and TTTP in sitagliptin
CN117347508A
Cited By
Analysis method for determining NTTP in sitagliptin phosphate
CN119757620A
Method for detecting nitrosamine impurity in metformin vildagliptin preparation and application thereof
CN120870398A
